Well-defined polymer-drug conjugate engineered with redox and pH-sensitive release mechanism for efficient delivery of paclitaxel.
about
Prodrug Strategies for PaclitaxelRedox-sensitive Pluronic F127-tocopherol micelles: synthesis, characterization, and cytotoxicity evaluation.Co-delivery of paclitaxel and tetrandrine via iRGD peptide conjugated lipid-polymer hybrid nanoparticles overcome multidrug resistance in cancer cells.The self-assembling camptothecin-tocopherol prodrug: An effective approach for formulating camptothecin.Tumor-targeted polymeric nanostructured lipid carriers with precise ratiometric control over dual-drug loading for combination therapy in non-small-cell lung cancerVitamin E succinate-conjugated F68 micelles for mitoxantrone delivery in enhancing anticancer activity.Strategies to release doxorubicin from doxorubicin delivery vehicles.pH-Sensitive stimulus-responsive nanocarriers for targeted delivery of therapeutic agents.Well-defined hydroxyethyl starch-10-hydroxy camptothecin super macromolecule conjugate: cytotoxicity, pharmacodynamics research, tissue distribution test and intravenous injection safety assessment.Effects of X-shaped reduction-sensitive amphiphilic block copolymer on drug delivery.Reduction-Sensitive Polymeric Micelles Based on Docetaxel-Polymer Conjugates Via Disulfide Linker for Efficient Cancer Therapy.Synthetic polypeptides: from polymer design to supramolecular assembly and biomedical application.Self-assembling prodrugs.Disulfide bond based polymeric drug carriers for cancer chemotherapy and relevant redox environments in mammals.pH and redox dual-sensitive polysaccharide nanoparticles for the efficient delivery of doxorubicin.The Effect of Size and Shape of RNA Nanoparticles on Biodistribution.Therapeutic efficacy of folate receptor-targeted amphiphilic cyclodextrin nanoparticles as a novel vehicle for paclitaxel delivery in breast cancer.Redox-sensitive micelles composed of disulfide-linked Pluronic-linoleic acid for enhanced anticancer efficiency of brusatol.Reversal of paclitaxel resistance in human ovarian cancer cells with redox-responsive micelles consisting of α-tocopheryl succinate-based polyphosphoester copolymers.Self-stabilized, hydrophobic or PEGylated paclitaxel polymer prodrug nanoparticles for cancer therapy
P2860
Q26745997-1E912BD5-1D09-4A40-A0D6-3B19767C9E5DQ33553597-FCE3656B-C06A-4F1B-83C5-60EA4AD175B6Q33634653-75603BD1-1D5A-4F2E-9FFF-91D92A9FE8BCQ35752126-BAC46EB6-69E4-4715-9943-CF1C8345F725Q36303474-4618B643-24FB-440B-A20F-ED1EA317895AQ37103470-41D1925A-0102-40EC-A637-6EA5D7F243F3Q38643071-92F674DC-6E34-419B-998A-890A3D074678Q38695106-813BDE99-47B3-41D5-9404-EF1368F15979Q38797396-6FD160B0-71BC-4E13-8FAC-400D15B51329Q38837166-2A7C2545-817C-4E8D-9B4B-28E8D800B504Q40231670-DB444C59-1A7A-44F0-8950-51ED9D68D9FAQ47638342-8195005B-BD89-4780-8E3D-D9D52C029DBFQ47904111-C4771192-70AE-40A2-AC9B-906028CCA745Q48228957-60623B7A-C785-43F1-822C-5BC68EE125A3Q48660128-CC23409B-4041-4A40-B988-7549E716E415Q50061940-5B8B01DB-2148-4AF9-9FFC-31DAF29102B4Q50852560-D7C9D30B-0B29-4A28-8EDD-71F1F4D82B0AQ52680601-B7915B7E-7837-4619-A672-148D8E394B09Q52783909-6B253DA3-3B0F-48DC-9AFC-EA7BA3D646BFQ57676452-F4B9B2FA-C020-4475-9140-4BDFE9EEC51C
P2860
Well-defined polymer-drug conjugate engineered with redox and pH-sensitive release mechanism for efficient delivery of paclitaxel.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Well-defined polymer-drug conj ...... icient delivery of paclitaxel.
@en
type
label
Well-defined polymer-drug conj ...... icient delivery of paclitaxel.
@en
prefLabel
Well-defined polymer-drug conj ...... icient delivery of paclitaxel.
@en
P2093
P1476
Well-defined polymer-drug conj ...... icient delivery of paclitaxel.
@en
P2093
Dawei Zhang
Huaiyu Liu
Shixian Lv
Wantong Song
Xuesi Chen
P304
P356
10.1016/J.JCONREL.2014.09.009
P407
P577
2014-09-16T00:00:00Z